The Index of Severity for Eosinophilic Esophagitis (I-SEE) Reflects Longitudinal Clinicopathologic Changes in

Andrew Dickerson1, Ayse Kolemen2, Keeler Kime2

  • 1Division of Allergy and Immunology, Department of Pediatrics, University of California San Diego and Rady Children's Hospital, San Diego, California; Division of Gastroenterology, Department of Pediatrics, University of California San Diego and Rady Children's Hospital, San Diego, California.

Insights

The Index of Severity for Eosinophilic Esophagitis (I-SEE) effectively tracks disease severity in children over time. This metric improved with treatment, correlating with better clinical outcomes like improved feeding and reduced fibrosis.

Area of Science:

  • Pediatric Gastroenterology
  • Eosinophilic Esophagitis Research
  • Disease Severity Metrics

Background:

  • The Index of Severity for Eosinophilic Esophagitis (I-SEE) is a novel scoring system.
  • Longitudinal data on I-SEE in pediatric cohorts are limited.
  • Understanding I-SEE's responsiveness is crucial for clinical management.

Purpose of the Study:

  • To evaluate I-SEE scores in a longitudinal pediatric cohort.
  • To assess the relationship between I-SEE and clinical features in children with EoE.
  • To determine I-SEE's responsiveness to treatment in routine care.

Main Methods:

  • Retrospective analysis of a prospectively enrolled pediatric cohort.
  • I-SEE calculated at diagnostic and follow-up endoscopies (mean 6.6 years).
  • Analysis of clinical, endoscopic, and histologic features, including symptoms and BMI.

Main Results:

  • At baseline, 43% had mild, 36% moderate, and 21% severe I-SEE scores.
  • Mean I-SEE decreased significantly from 9.7 at first follow-up to 3.9 by the last instance (P < .001).
  • Severe baseline I-SEE correlated with low BMI and poor feeding, which improved over time. Fibrosis also improved (P < .01).

Conclusions:

  • I-SEE is a responsive severity metric in children with EoE undergoing long-term treatment.
  • Baseline I-SEE scores correlate with specific clinical features like BMI and feeding difficulties.
  • I-SEE aids in monitoring treatment effectiveness in pediatric eosinophilic esophagitis.
Abstract

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
116
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
183
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
127
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
96
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
109
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
339